# US 2025/0144226 A1 · Methods and compounds for the treatment of genetic disease

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0144226 A1
- Document ID: US20250144226A1
- Status: Published application
- Kind: A1
- Application number: 17/046,465
- Filed: 2019-04-11
- Published: 2025-05-08
- Earliest claimed: 2018-04-11
- Assignees: Design Therapeutics, Inc.
- Applicants: Design Therapeutics, Inc.
- Inventors: Aseem ANSARI; Pratik SHAH
- Web page: https://patentgrep.com/patent/US20250144226A1

## CPC

- A61K 47/595: {Polyamides, e.g. nylon (polyamino acids A61K47/62)}
- C07D 401/14: containing three or more hetero rings
- A61K 47/6455: {Polycationic oligopeptides, polypeptides or polyamino acids, e.g. for complexing nucleic acids}
- A61P 21/00: Drugs for disorders of the muscular or neuromuscular system
- C07D 403/14: containing three or more hetero rings
- C08G 69/02: Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C08G: MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS

## Abstract

The present disclosure relates to compounds and methods which may be useful for modulating the expression of cnbp and treating diseases and conditions in which cnbp plays an active role.

## Claims

### Claim 1

A transcription modulator molecule having a first terminus, a second terminus, and an oligomeric backbone, wherein:
a) the first terminus comprises a DNA-binding moiety capable of noncovalently binding to a nucleotide repeat sequence CCTG;
b) the second terminus comprises a protein-binding moiety binding to a regulatory molecule that modulates an expression of a gene comprising the nucleotide repeat sequence CCTG; and
c) the oligomeric backbone comprising a linker between the first terminus and the second terminus, with the proviso that the second terminus is not a Brd4 binding moiety.

### Claim 2 (depends on 1)

The transcription modulator molecule of claim 1, wherein the first terminus comprises a polyamide selected from the group consisting of a linear polyamide, a hairpin polyamide, a H-pin polyamide, an overlapped polyamide, a slipped polyamide, a cyclic polyamide, a tandem polyamide, and an extended polyamide.

### Claim 3 (depends on 1, 2)

The transcription modulator molecule of claim 1 or 2, wherein the first terminus comprises a linear polyamide.

### Claim 4 (depends on 1, 2)

The transcription modulator molecule of claim 1 or 2, wherein the first terminus comprises a hairpin polyamide.

### Claim 5 (depends on 2, 3, 4)

The transcription modulator molecule of any one of claims 2-4, wherein the polyamide is capable of binding the DNA with an affinity of less than 500 nM.

### Claim 6 (depends on 1, 2, 3, 4, 5)

The transcription modulator molecule of any one of claims 1-5, wherein the first terminus comprises —NH-Q-C(O)—, wherein Q is an optionally substituted C6-10 arylene, optionally substituted 4-10 membered heterocyclene, optionally substituted 5-10 membered heteroarylene group, or an optionally substituted alkylene group.

### Claim 7 (depends on 1, 2, 3, 4, 5, 6)

The transcription modulator molecule of any one of claims 1-6, wherein the first terminus comprises at least three heteroaromatic carboxamide moieties comprising at least one heteroatom selected from O, N, and S, and at least one aliphatic amino acid residue chosen from the group consisting of glycine, β-alanine, γ-aminobutyric acid, 2,4-diaminobutyric acid, and 5-aminovaleric acid.

### Claim 8 (depends on 7)

The transcription modulator molecule of claim 7, wherein the heteroaromatic carboxamide moiety is a monocyclic or bicyclic moiety.

### Claim 9 (depends on 7)

The transcription modulator molecule of claim 7, wherein the first terminus comprises one or more carboxamide moieties selected from the group consisting of optionally substituted pyrrole carboxamide monomer, optionally substituted imidazole carboxamide monomer, and β-alanine monomer.

### Claim 10 (depends on 7, 8, 9)

The transcription modulator molecule of any one of claims 7-9, wherein the carboxamide moieties are selected based on the pairing principle shown in Table 1A, Table 1B, Table 1C, or Table 1D.

### Claim 11 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10)

The transcription modulator molecule of any one of claims 1-10, wherein the first terminus comprises Im corresponding to the nucleotide G, Py or β corresponding to the nucleotide pair C, Py or β corresponding to the nucleotide pair A, Py, β, or Hp corresponding to the nucleotide T, and wherein Im is N-methyl imidazole, Py is N-methyl pyrrole, Hp is 3-hydroxy N-methyl pyrrole, and β-alanine.

### Claim 12 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10)

The transcription modulator molecule of any one of claims 1-10, wherein the first terminus comprises Im/Py to correspond to the nucleotide pair G/C, Py/Im to correspond to the nucleotide pair C/G, Py/Py to correspond to the nucleotide pair A/T, Py/y to correspond to the nucleotide pair T/A, Hp/Py to correspond to the nucleotide pair T/A, and wherein Im is N-methyl imidazole, Py is N-methyl pyrrole, and Hp is 3-hydroxy N-methyl pyrrole.

### Claim 13 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)

The transcription modulator molecule of any one of claims 1-12, wherein the first terminus comprises a structure of formula (A-1)
-L1-[A-R]p-E1 (A-1)
wherein:
each [A-R] appears p times and p is an integer in the range of 1 to 10,
L1 is a bond, a C1-6 alkylene, —NR1—C1-6 alkylene-C(O)—, —NR1—C(O)—, —NR1—C1-6 alkylene, —O—, or —O—C1-6 alkylene;
A is selected from a bond, C1-10 alkylene, —CO—, —NR1—, —CONR1—, —CONR1C1-4alkylene-, —NR1CO—C1-10 alkylene-, —C(O)O—, —O—, —S—, —C(═S)—NH—, —C(O)—NH—NH—, —CH═CH—CH2—, —C(O)—N═N—, or —C(O)—CH═CH—;
each R is an optionally substituted C6-10 arylene group, optionally substituted 4-10 membered heterocyclene, optionally substituted 5-10 membered heteroarylene group, or an optionally substituted alkylene;
E1 is selected from the group consisting of optionally substituted C6-10 aryl, optionally substituted 4-10 membered heterocyclyl, optionally substituted 5-10 membered heteroaryl, or an optionally substituted alkyl, and optionally substituted amine.

### Claim 14 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)

The transcription modulator molecule of any one of claims 1-12, wherein the first terminus comprises a structure of
wherein:
L is a linker selected from —C1-12 alkylene-CR1, CH, N, —C1-6 alkylene-N, —C(O)N, —NR1—C1-6 alkylene-CH, or —O—C0-6 alkylene-CH,
p is an integer in the range of 1 to 10,
q is an integer in the range of 1 to 10,
each A is independently selected from a bond, C1-10 alkylene, —C1-10 alkylene-C(O)—, —C1-10 alkylene-NR1—, —CO—, —NR1—, —CONR1—, —CONR1C1-4alkylene-, —NR1CO—C1-4alkylene-, —C(O)O—, —O—, —S—, —C(═S)—N—, —C(O)—NH—NH—, —C(O)—N═N—, or —C(O)—CH═CH—;
each R is an optionally substituted C6-10 arylene group, optionally substituted 4-10 membered heterocyclene, optionally substituted 5-10 membered heteroarylene group, or an optionally substituted alkylene;
each E1 and E2 are selected from the group consisting of optionally substituted C6-10 aryl, optionally substituted 4-10 membered heterocyclyl, optionally substituted 5-10 membered heteroaryl, or an optionally substituted alkyl, and optionally substituted amine; and
2≤p+q≤20.

### Claim 15 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)

The transcription modulator molecule of any one of claims 1-12, wherein the first terminus comprises a structure of Formula (A-3)
-L1-[A-R]p-L2-[R-A]q-E1 (A-3)
wherein:
L1 is a bond, a C1-6 alkylene, —NH—C0-6 alkylene-C(O)—, —N(CH3)—C0-6 alkylene or —O—C0-6 alkylene,
L2 is a bond, a C1-6 alkylene, —NH—C0-6 alkylene-C(O)—, —N(CH3)—C0-6 alkylene, —O—C0-6 alkylene, —(CH2)a-NR1—(CH2)b-, —(CH2)a-, —(CH2)a-O—(CH2)b-, —(CH2)a-CH(NHR1)—, —(CH2)a-CH—(NHR1)—, —(CR2R3)a-, or —(CH2)a-CH(NR13)+—(CH2)b-;
each a and b are independently an integer between 2 and 4;
R1 is H, an optionally substituted C1-6 alkyl, a an optionally substituted C3-10 cycloalkyl, an optionally substituted C6-10 aryl, an optionally substituted 4-10 membered heterocyclyl, or an optionally substituted 5-10 membered heteroaryl;
each R2 and R3 are independently H, halogen, OH, NHAc, or C1-4 alky. each [A-R] appears p times and p is an integer in the range of 1 to 10,
each [R-A] appears q times and q is an integer in the range of 1 to 10,
each A is selected from a bond, C1-10 alkyl, —CO—, —NR1—, —CONR1—, CONR1C1-4alkyl-, —NR1CO—C1-4alkyl-, —C(O)O—, —O—, —S—, —C(═S)—NH—, —C(O)—NH—NH—, —C(O)—N═N—, or —C(O)—CH═CH— each R is an optionally substituted C6-10 arylene group, optionally substituted 4-10 membered heterocyclene, optionally substituted 5-10 membered heteroarylene group, or an optionally substituted alkylene;
E1 is selected from the group consisting of optionally substituted C6-10 aryl, optionally substituted 4-10 membered heterocyclyl, optionally substituted 5-10 membered heteroaryl, or an optionally substituted alkyl, and optionally substituted amine; and
2≤p+q≤20.

### Claim 16 (depends on 13, 14, 15)

The transcription modulator molecule of any one of claims 13-15, wherein each E1 independently comprises optionally substituted thiophene-containing moiety, optionally substituted pyrrole containing moiety, optionally substituted imidazole containing moiety, and optionally substituted amine.

### Claim 17 (depends on 14)

The transcription modulator molecule of claim 14, wherein each E2 independently comprises optionally substituted thiophene-containing moiety, optionally substituted pyrrole containing moiety, optionally substituted imidazole containing moiety, and optionally substituted amine.

### Claim 18 (depends on 16, 17)

The transcription modulator molecule of claim 16 or 17, wherein each E1 and E2 are independently selected from the group consisting of optionally substituted N-methylpyrrole, optionally substituted N-methylimidazole, optionally substituted benzimidazole moiety, and optionally substituted 3-(dimethylamino)propanamidyl.

### Claim 19 (depends on 18)

The transcription modulator molecule of claim 18, wherein each E1 and E2 independently comprises thiophene, benzthiophene, C—C linked benzimidazole/thiophene-containing moiety, or C—C linked hydroxybenzimidazole/thiophene-containing moiety,

### Claim 20 (depends on 18, 19)

The transcription modulator of claim 18 or 19, wherein each E1 or E2 are independently selected from the group consisting of isophthalic acid; phthalic acid; terephthalic acid; morpholine; N,N-dimethylbenzamide; N,N-bis(trifluoromethyl)benzamide; fluorobenzene; (trifluoromethyl)benzene; nitrobenzene; phenyl acetate; phenyl 2,2,2-trifluoroacetate; phenyl dihydrogen phosphate; 2H-pyran; 2H-thiopyran; benzoic acid; isonicotinic acid; and nicotinic acid; wherein one, two or three ring members in any of these end-group candidates can be independently substituted with C, N, S or O; and where any one, two, three, four or five of the hydrogens bound to the ring can be substituted with R5, wherein R5 may be independently selected for any substitution from H, OH, halogen, C1-10 alkyl, NO2, NH2, C1-10 haloalkyl, —OC1-10 haloalkyl, COOH, CONR′R″; wherein each R′ and R″ are independently H, C1-10 alkyl, C1-10 haloalkyl, —C1-10 alkoxyl.

### Claim 21 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)

The transcription modulator molecule of claim any one of claims 1-12, wherein the first terminus comprises Formula (A-4) or Formula (A-5)
W1—NH-Q1-C(O)—W2—NH-Q2-C(O)—W3— . . . —NH-Qm−1C(O)Wm—NH-Qm-C(O)-E (A-4)
or
W1—C(O)-Q1-NH—W2—C(O)-Q2NH—W3— . . . —C(O)-Qm−1NH—Wm—C(O)-Qm−1-NH—Wm+1-E (A-5)
Wherein:
each Q1 Q2 . . . and Qm are independently an optionally substituted C6-10 arylene group, optionally substituted 4-10 membered heterocyclene, optionally substituted 5-10 membered heteroarylene group, or an optionally substituted alkylene;
each W1 W2 . . . and Wm are independently a bond, a C1-6 alkylene, —NH—C0-6 alkylene-C(O)—, —N(CH3)—C0-6 alkylene, —C(O)—, —C(O)—C1-10alkylene, or —O—C0-6 alkylene;
m is an integer between 2 and 10; and
E is selected from the group consisting of optionally substituted C6-10 aryl, optionally substituted 4-10 membered heterocyclyl, optionally substituted 5-10 membered heteroaryl, or an optionally substituted alkyl, and optionally substituted amine.

### Claim 22 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21)

The transcription modulator molecule of claim any one of claims 1-21, wherein the first terminus comprises at least one C3-5 achiral aliphatic or heteroaliphatic amino acid.

### Claim 23 (depends on 22)

The transcription modulator molecule of claim 22, wherein the first terminus comprises one or more subunits selected from the group consisting of optionally substituted pyrrole, optionally substituted imidazole, optionally substituted thiophene, optionally substituted furan, optionally substituted beta-alanine, γ-aminobutyric acid, (2-aminoethoxy)-propanoic acid, 3((2-aminoethyl)(2-oxo-2-phenyl-1λ2-ethyl)amino)-propanoic acid, or dimethylaminopropylamide monomer.

### Claim 24 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)

The transcription modulator molecule of any one of claims 1-12, wherein the first terminus comprises a polyamide having the structure of
wherein:
each A1 is —NH— or —NH—(CH2)m—CH2—C(O)—NH—;
each R1 is an optionally substituted C6-10 arylene group, optionally substituted 4-10 membered heterocyclene, optionally substituted 5-10 membered heteroarylene group, or optionally substituted alkylene; and
n is an integer between 1 and 6.

### Claim 25 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 24)

The transcription modulator molecule as recited in any one of claims 1-12 and 24, wherein the first terminus has a structure of Formula (A-7):
or a salt thereof, wherein:
E is an end subunit which comprises a moiety chosen from a heterocyclic group or a straight chain aliphatic group, which is chemically linked to its single neighbor;
each X1, X2, X3 are independently CR1, N, NR2, O, or S;
each Y1, Y2, Y3 are independently CR1, N, NR2, O, or S;
each Z1, Z2, Z3 are independently CR1, N, NR2, O, or S;
each R1 is independently H, —OH, halogen, C1-6 alkyl, C1-6 alkoxyl;
each R2 is independently H, C1-6 alkyl or C1-6alkylamine; and
n is an integer between 1 and 5.

### Claim 26 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 24)

The transcription modulator molecule as recited in any one of claims 1-12 and 24, wherein the first terminus has the structure of Formula (A-8):
or a salt thereof, wherein:
E is an end subunit which comprises a moiety chosen from a heterocyclic group or a straight chain aliphatic group, which is chemically linked to its single neighbor;
each X1, X2, X3 are independently CR1, N, NR2, O, or S;
each Y1, Y2, Y3 are independently CR1, N, NR2, O, or S;
each Z1, Z2, Z3 are independently CR1, N, NR2, O, or S;
each R1 is independently H, —OH, halogen, C1-6 alkyl, C1-6 alkoxyl;
each R2 is independently H, C1-6 alkyl or C1-6alkylaminen is an integer between 1 and 5.

### Claim 27 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 24)

The transcription modulator molecule as recited in any one of claims 1-12 and 24, wherein the first terminus has the structure of Formula (A-9):
or a salt thereof, wherein:
W is a spacer; and
E is an end subunit which comprises a moiety chosen from a heterocyclic ring or a straight chain aliphatic segment, which is chemically linked to its single neighbor; and
n is an integer between 1 and 5.

### Claim 28 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 24)

The transcription modulator molecule of any one of claims 1-12 and 24, wherein the first terminus comprises a polyamide having the structure of formula (A-10)
wherein:
each Y1, Y2, Y3 are independently CR1, N, NR2, O, or S;
each Z1, Z2, Z3 are independently CR1, N, NR2, O, or S;
each R1 is independently H, —OH, halogen, C1-6 alkyl, C1-6 alkoxyl;
each R2 is independently H, C1-6 alkyl or C1-6alkylamine;
each W1 and W2 are independently a bond, NH, a C1-6 alkylene, —NH—C1-6 alkylene, —N(CH3)—C0-6 alkylene, —C(O)—, —C(O)—C1-10alkylene, or —O—C0-6 alkylene; and
n is an integer between 2 and 11.

### Claim 29 (depends on 25, 26, 27, 28)

The transcription modulator molecule of any one of claims 25-28, wherein R1 is selected from the group consisting of H, COH, Cl, NO, N-acetyl, benzyl, C1-6 alkyl, C1-6 alkoxyl, C1-6 alkenyl, C1-6 alkynyl, C1-6alkylamine, —C(O)NH—(CH2)1-4—C(O)NH—(CH2)1-4—NRaRb; and each Ra and Rb are independently hydrogen or C1-6 alkyl.

### Claim 30 (depends on 25, 26, 27, 28)

The transcription modulator molecule of any one of claims 25-28, wherein R2 is independently selected from the group consisting of H, C1-6 alkyl, and C1-6 alkylNH2, preferably H, methyl, or isopropyl.

### Claim 31 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30)

The transcription modulator molecule of any one of claims 1-30, wherein the first terminus comprises a polyamide having one or more subunits independently selected from
wherein Z is H, NH2, C1-6 alkyl, C1-6 haloalkyl or C1-6 alkyl-NH2.

### Claim 32 (depends on 31)

The transcription modulator molecule of claim 31, wherein the first terminus comprises one or more subunits selected from the group consisting of optionally substituted N-methylpyrrole, optionally substituted N-methylimidazole, and β-alanine.

### Claim 33 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32)

The transcription modulator molecule of any one of claims 1-32, wherein the first terminus does not have a structure of

### Claim 34 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33)

The transcription modulator molecule of any one of claims 1-33, wherein the linker has a length of less than about 50 Angstroms.

### Claim 35 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34)

The transcription modulator molecule of any one of claims 1-34, wherein the linker has a length of about 20 to 30 Angstroms.

### Claim 36 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35)

The transcription modulator molecule of any one of claims 1-35, wherein the linker comprises between 5 and 50 chain atoms.

### Claim 37 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36)

The transcription modulator molecule of any one of claims 1-36, wherein the linker comprises a multimer having from 2 to 50 spacing moieties, and
wherein the spacing moiety is independently selected from the group consisting of —((CRaRb)x—O)y—, —((CRaRb)x—NR1)y—, —((CRaRb)x—CH═CH—(CRaRb)x—O)y—, optionally substituted —C1-12 alkyl, optionally substituted C2-10 alkenyl, optionally substituted C2-10 alkenyl, optionally substituted C6-10 arylene, optionally substituted C3-7 cycloalkylene, optionally substituted 5- to 10-membered heteroarylene, optionally substituted 4- to 10-membered heterocycloalkylene, amino acid residue, —O—, —C(O)NR1—, —NR1C(O)—, —C(O)—, —NR1—, —C(O)O—, —O—, —S—, —S(O)—, —SO2—, —SO2NR1—, —NR1SO2—, and —P(O)OH—, and any combinations thereof;
each x is independently 2-4;
each y is independently 1-10; and
each Ra and Rb are independently selected from hydrogen, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted alkoxy, optionally substituted amino, carboxyl, carboxyl ester, acyl, acyloxy, acyl amino, amino acyl, optionally substituted alkylamide, sulfonyl, optionally substituted thioalkoxy, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted cycloalkyl, and optionally substituted heterocyclyl; and
each R1 is independently a hydrogen or an optionally substituted C1-6 alkyl.

### Claim 38 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37)

The transcription modulator molecule of any one of claims 1-37, wherein the oligomeric backbone comprises -(T1-V1)a-(T2-V2)b-(T3-V3)c-(T4-V4)d-(T5-V5)e—, and
wherein a, b, c, d and e are each independently 0 or 1, where the sum of a, b, c, d and e is 1 to 5;
T1, T2, T3, T4 and T5 are each independently selected from optionally substituted (C1-C12)alkylene, optionally substituted alkenylene, optionally substituted alkynylene, (EA)w, (EDA)m, (PEG)n, (modified PEG)n, (AA)p, —(CR1OH)h—, optionally substituted (C6-C10) arylene, optionally substituted C3-7 cycloalkylene, optionally substituted 5- to 10 membered heteroarylene, optionally substituted 4- to 10-membered heterocycloalkylene, an acetal group, a disulfide, a hydrazine, a carbohydrate, a beta-lactam, and an ester,
w is an integer from 1 to 20;
m is an integer from 1 to 20;
n is an integer from 1 to 30;
p is an integer from 1 to 20;
b is an integer from 1 to 12;
EA has the following structure
EDA has the following structure:
where each q is independently an integer from 1 to 6, each x is independently an integer from 1 to 4, and each r is independently 0 or 1;
(PEG)n has the structure of —(CR1R2—CR1R2—O)n—CR1R2—;
(modified PEG)n has the structure of —(CR1R2—CR1R2—O) in (PEG)n with —(—CH2—CR1═CR1—CH2—O)—or —(CR1R2—CR1R2—S)
n is an integer in the range of 2-10;
AA is an amino acid residue;
V1, V2, V3, V4 and V5 are each independently selected from the group consisting of a covalent bond, —CO—, —NR1—, —CONR1—, —NR1CO—, —CONR1C1-4alkyl-, —NR1CO—C1-4alkyl-, —C(O)O—, —OC(O)—, —O—, —S—, —S(O)—, —SO2—, —SO2NR1—, —NR1SO2— and —P(O)OH—, and
each R1, R2 and R3 are independently selected from hydrogen, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, halogen, alkoxy, substituted alkoxy, amino, substituted amino, carboxyl, carboxyl ester, acyl, acyloxy, acyl amino, amino acyl, alkylamide, substituted alkylamide, sulfonyl, thioalkoxy, substituted thioalkoxy, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocyclyl, and substituted heterocyclyl.

### Claim 39 (depends on 38)

The transcription modulator molecule of claim 38, wherein T1, T2, T3, and T4, and T5 are each independently selected from (C1-C12)alkyl, substituted (C1-C12)alkyl, (EA)w, (EDA)m, (PEG)n, (modified PEG)n, (AA)p, —(CR1OH)h—, phenyl, substituted phenyl, piperidin-4-amino (P4A), piperidine-3-amino, piperazine, pyrrolidin-3-amino, azetidine-3-amino, para-amino-benzyloxycarbonyl (PABC), meta-amino-benzyloxycarbonyl (MABC), para-amino-benzyloxy (PABO), meta-amino-benzyloxy (MABO), para-aminobenzyl, an acetal group, a disulfide, a hydrazine, a carbohydrate, a beta-lactam, an ester, (AA)p-MABC-(AA)p, (AA)p-MABO-(AA)p, (A A)p-PABO-(AA)p and (AA)p-PABC-(AA)p, piperidin-4-amino (P4A) is

### Claim 40 (depends on 38)

The transcription modulator molecule of claim 38, wherein T1, T2, T3, T4 and T5 are each independently selected from (C1-C12)alkyl, substituted (C1-C12)alkyl, (EA)w, (EDA)m, (PEG)n, (modified PEG)n, (AA)p, —(CR1OH)h—, optionally substituted (C6-C10) arylene, 4-10 membered heterocycloalkene, optionally substituted 5-10 membered heteroarylene.

### Claim 41 (depends on 38)

The transcription modulator molecule of claim 38, wherein T4 or T5 is an optionally substituted (C6-C10) arylene.

### Claim 42 (depends on 38)

The transcription modulator molecule of claim 38, wherein T4 or T5 is phenylene or substituted phenylene.

### Claim 43 (depends on 1)

The transcription modulator molecule of claim 1, wherein T1, T2, T3, T4 and T5 and V1, V2, V3, V4 and V5 are selected from the following table:
T1
V1
T2
V2
T3
V3
T4
V4
T5
V5
(C1-
CONR11
(EA)w
CO
(PEG)n
NR11CO
—
—
—
—
C12)alkylene
(C1-
CONR11
(EA)w
CO
(PEG)n
O
arylene
NR11CO
—
—
C12)alkylene
(C1-
CONR11
(EA)w
CO
(PEG)n
O
Substituted
NR11CO
—
—
C12)alkylene
arylene
(C1-
CONR11
(EA)w
CO
(PEG)n
O
NR11CO
(C1-
Substituted
NR11CO
C12)alkylene
C12)alkyl
arylene
(C1-
CONR11
(EA)w
CO
(C1-
NR11COC1-4alkyl
Substituted
NR11
—
—
C12)alkylene
C12)alkyl
arylene
(C1-
CONR11
(EA)w
CO
(PEG)n
O
Substituted
—
—
—
C12)alkylene
arylene
(PEG)n
CONR11C1-4alkyl
—
—
—
—
—
—
—
—
(EA)w
CO
(C1-
CONR11C1-4alkyl
—
—
—
—
—
—
C12)alkyl
(C1-
CONR11
(EA)w
CO
(PEG)n
NR11COC1-4alkyl
—
—
—
—
C12)alkylene
(EA)w
CO
(PEG)n
O
phenyl
NR11COC1-4alkyl
—
—
—
—
(C1-
CONR11
(PEG)n
CO
—
—
—
—
—
—
C12)alkylene
(C1-
CONR11
(EA)w
CO
(modified
O
arylene
NR11CO
—
—
C12)alkylene
PEG)n

### Claim 44 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43)

The transcription modulator molecule of any one of claims 1-43, wherein the linker comprises
or any combination thereof, and r is an integer between 1 and 10, preferably between 3 and 7, and X is O, S, or NR1.

### Claim 45 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44)

The transcription modulator molecule of any one of claims 1-44, wherein the linker comprise a
having at least one —(CH2—CH2—O) replaced with —((CRaRb)x—CH═CH—(CRaRb)x—O)—, or any combinations thereof; wherein W′ is absent, (CH2)1-5, —(CH2)1-5O, (CH2)1-5—C(O)NH—(CH2)1-5—O, (CH2)1-5—C(O)NH—CH—2)1-5, —(CH2)1-5NHC(O)—(CH2)1-5—O, —(CH2)1-5—NHC(O)—(CH2)1-5—; E3 is an optionally substituted C6-10 arylene group, optionally substituted 4-10 membered heterocycloalkylene, or optionally substituted 5-10 membered heteroarylene: X is O, S, or N; r is an integer between 1 and 10.

### Claim 46 (depends on 45)

The transcription modulator molecule of claim 45, wherein E3 is a phenylene or substituted phenylene.

### Claim 47 (depends on 45)

The transcription modulator molecule of claim 45, wherein the linker comprise a

### Claim 48 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45)

The transcription modulator molecule of any one of claims 1-45, wherein the linker comprises —X(CH2)m(CH2CH2O)n—, wherein X is —O—, —NH—, or —S—, wherein m is 0 or greater and n is at least 1.

### Claim 49 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45)

The transcription modulator molecule of any one of claims 1-45, wherein the linker comprises
following the second terminus, wherein Rc is selected from a bond, —N(Ra)—, —O—, and —S—; Rd is selected from —N(Ra)—, —O—, and —S—; and Re is independently selected from hydrogen and optionally substituted C1-6 alkyl.

### Claim 50 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45)

The transcription modulator molecule of any one of claims 1-45, wherein the linker comprises one or more structure selected from
—C1-12 alkyl, arylene, cycloalkylene, heteroarylene, heterocycloalkylene, —O—, —C(O)NR′—, —C(O)—, —NR′—, —(CH2CH2CH2O)y—, and —(CH2CH2CH2NR′)y—, and each r and y are independently 1-10, wherein each R′ is independently a hydrogen or C1-6 alkyl.

### Claim 51 (depends on 50)

The transcription modulator molecule of claim 50, wherein the linker comprises
and r is 3-7.

### Claim 52 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51)

The transcription modulator molecule of any one of claims 1-51, wherein the linker comprises —N(Ra)(CH2)xN(Rb)(CH2)xN—, wherein Ra or Rb are independently selected from hydrogen or optionally substituted C1-C6 alkyl and each x is independently an integer in the range of 1-6.

### Claim 53 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52)

The transcription modulator molecule of any one of claims 1-52, wherein the linker comprises —(CH2—C(O)N(R′)—(CH2)q—N(R*)—(CH2)q—N(R′)C(O)—(CH2)x—C(O)N(R′)-A-, —(CH2)x—C(O)N(R′)—(CH2 CH2O)y(CH2)x—C(O)N(R′)-A-, —C(O)N(R′)—(CH2)q—N(R*)—(CH2)q—N(R′)C(O)—(CH2)x-A-, —(CH2)x—O—(CH2 CH2O)y—(CH2)x—N(R′)C(O)—(CH2)x-A-, or —N(R′)C(O)—(CH2)—C(O)N(R′)—(CH2)x—O(CH2CH2O)y(CH2)x-A-; wherein R* is methyl, R′ is hydrogen; each y is independently an integer from 1 to 10; each q is independently an integer from 2 to 10; each x is independently an integer from 1 to 10; and each A is independently selected from a bond, an optionally substituted C1-12 alkyl, an optionally substituted C6-10 arylene, optionally substituted C3-7 cycloalkylene, optionally substituted 5- to 10-membered heteroarylene, and optionally substituted 4- to 10-membered heterocycloalkylene.

### Claim 54 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53)

The transcription modulator molecule of any one of claims 1-53, wherein the linker is joined with the first terminus with a group selected from —CO—, —NR1—, —CONR1—, —NR1O—, —CONR1C1-4alkyl-, —NR1CO—C1-4alkyl-, —C(O)O—, —OC(O)—, —O—, —S—, —S(O)—, —SO2—, —SO2NR1—, —NR1SO2—, —P(O)OH—, —((CH2)x—O)—, —((CH2)y—NR1)—, optionally substituted —C1-12alkylene, optionally substituted C2-10alkenylene, optionally substituted C2-10alkynylene, optionally substituted C6-10 arylene, optionally substituted C3-7 cycloalkylene, optionally substituted 5- to 10-membered heteroarylene, and optionally substituted 4- to 10-membered heterocycloalkylene, wherein each x is independently 1-4, each y is independently 1-4, and each R1 is independently a hydrogen or optionally substituted C1-6alkyl.

### Claim 55 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54)

The transcription modulator molecule of any one of claims 1-54, wherein the linker is joined with the first terminus with a group selected from —C—, —NR1—, C1-12alkyl, —CONR1—, and —NR1CO—.

### Claim 56 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55)

The transcription modulator molecule of any one of claims 1-55, wherein the linker is joined with second terminus with a group selected from —CO—, —NR1—, —CONR1—, —NR1CO—, —CONR1C1-4alkyl-, —NR1CO—C1-4alkyl-, —C(O)O—, —OC(O)—, —O—, —S—, —S(O)—, —SO2—, —SO2NR1—, —NR1SO2—, —P(O)OH—, —((CH2)x—O)—, —((CH2)y—NR1)—, optionally substituted —C1-12 alkylene, optionally substituted C2-10 alkenylene, optionally substituted C2-10 alkynylene, optionally substituted C6-10 arylene, optionally substituted C3-7 cycloalkylene, optionally substituted 5- to 10-membered heteroarylene, and optionally substituted 4- to 10-membered heterocycloalkylene, wherein each x is independently 1-4, each y is independently 1-4, and each R1 is independently a hydrogen or optionally substituted C1-6 alkyl.

### Claim 57 (depends on 56)

The transcription modulator molecule of claim 56, wherein the linker is joined with second terminus with a group selected from —CO—, —NR1—, —CONR1—, —NR1CO—, —((CH2)x—O)—, —((CH2)y—NR1)—, —O—, optionally substituted —C1-12 alkyl, optionally substituted C6-10 arylene, optionally substituted C3-7 cycloalkylene, optionally substituted 5- to 10-membered heteroarylene, and optionally substituted 4- to 10-membered heterocycloalkylene, wherein each x is independently 1-4, each y is independently 1-4, and each R1 is independently a hydrogen or optionally substituted C1-6 alkyl.

### Claim 58 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57)

The transcription modulator molecule of any one of claims 1-57, wherein the second terminus binds the regulatory molecule with an affinity of less than 200 nM.

### Claim 59 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58)

The transcription modulator molecule of any one of claims 1-58, wherein the second terminus comprises one or more optionally substituted C6-10 aryl, optionally substituted C4-10 carbocyclic, optionally substituted 4 to 10 membered heterocyclic, or optionally substituted 5 to 10 membered heteroaryl.

### Claim 60 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59)

The transcription modulator molecule of any one of claims 1-59, wherein the protein-binding moiety binds to the regulatory molecule that is selected from the group consisting of a CREB binding protein (CBP), a P300, an O-linked β-N-acetylglucosamine-transferase- (OGT-), a P300-CBP-associated-factor- (PCAF-), histone methyltransferase, histone demethylase, chromodomain, a cyclin-dependent-kinase-9- (CDK9-), a nucleosome-remodeling-factor-(NURF-), a bromodomain-PHD-finger-transcription-factor- (BPTF-), a ten-eleven-translocation-enzyme-(TET-), a methylcytosine-dioxygenase- (TET1-), histone acetyltransferase (HAT), a histone deacetalyse (HDAC),, a host-cell-factor-1(HCF1-), an octamer-binding-transcription-factor-(OCT1-), a P-TEFb-, a cyclin-T1-, a PRC2-, a DNA-demethylase, a helicase, an acetyltransferase, a histone-deacetylase, methylated histone lysine protein.

### Claim 61 (depends on 60)

The transcription modulator molecule of claim 60, wherein the second terminus comprises a moiety that binds to an O-linked β-N-acetylglucosamine-transferase(OGT), or CREB binding protein (CBP).

### Claim 62 (depends on 60)

The transcription modulator molecule of claim 60, wherein the protein binding moiety is a residue of a compound that binds to an O-linked β-N-acetylglucosamine-transferase(OGT), or CREB binding protein (CBP).

### Claim 63 (depends on 1)

The transcription modulator molecule of claim 1, wherein the protein binding moiety is a residue of a compound selected from Table 2.

### Claim 64 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62)

The transcription modulator molecule of any one of claims 1-62, wherein the protein binding moiety is a residue of a compound having a structure of Formula (C-1)
wherein:
Xa is —NHC(O)—, —C(O)—NH—, —NHSO2—, or —SO2NH—;
Aa is selected from an optionally substituted —C1-12alkyl, optionally substituted —C2-10 alkenyl, optionally substituted —C2-10 alkynyl, optionally substituted —C1-12 alkoxyl, optionally substituted —C1-12 haloalkyl, optionally substituted C6-10 aryl, optionally substituted C3-7 cycloalkyl, optionally substituted 5- to 10 membered heteroaryl, and optionally substituted 5- to 10-membered heterocycloalkyl;
Xb is a bond, NH, NH—C1-10alkylene, —C1-12 alkyl, —NHC(O)—, or —C(O)—NH—;
Ab is selected from an optionally substituted —C1-12 alkyl, optionally substituted —C2-10 alkenyl, optionally substituted —C2-10 alkynyl, optionally substituted —C1-12 alkoxyl, optionally substituted —C1-12 haloalkyl, optionally substituted C6-10 aryl, optionally substituted C3-7 cycloalkyl, optionally substituted 5- to 10 membered heteroaryl, and optionally substituted 4- to 10-membered heterocycloalkyl; and
each R1a, R2a, R3a, R4a are independently selected from the group consisting of H, OH, —NO2, halogen, amine, COOH, COOC1-10alkyl, —NHC(O)—optionally substituted —C1-12 alkyl, —NHC(O)(CH2)1-4NR′R″, —NHC(O)(CH2)0-4 CHR′(NR′R″), —NHC(O)(CH2))0-4 CHR′R″, —NHC(O)(CH2)0-4—C3-7 cycloalkyl, —NHC(O)(CH2)0-4-5- to 10-membered heterocycloalkyl, NHC(O)(CH2)0-4C6-10 aryl, —NHC(O)(CH2)0-4-5- to 10-membered heteroaryl, —(CH2)1-4—C3-7 cycloalkyl, —(CH2)1-4-5- to 10-membered heterocycloalkyl, —CH2)1-4C6-10 aryl, —(CH2)1-4-5- to 10-membered heteroaryl, optionally substituted —C2-10 alkenyl, optionally substituted —C2-10alkynyl, optionally substituted —C1-12 alkoxyl, optionally substituted —C1-12 haloalkyl, optionally substituted C6-10 aryl, optionally substituted C3-7 cycloalkyl, optionally substituted 5- to 10-membered heteroaryl, and optionally substituted 4- to 10-membered heterocycloalkyl.

### Claim 65 (depends on 64)

The transcription modulator molecule of claim 64, wherein the protein binding moiety is a residue of a compound having a structure of Formula (C-2)
wherein R5a is independently selected from the group consisting of H, COOC1-10alkyl, —NHC(O)—optionally substituted —C1-12 alkyl, optionally substituted —C2-10 alkenyl, optionally substituted —C2-10 alkynyl, optionally substituted —C1-12 alkoxyl, optionally substituted —C1-12 haloalkyl, optionally substituted C6-10 aryl, optionally substituted C3-7 cycloalkyl, optionally substituted 5- to 10-membered heteroaryl, and optionally substituted 5- to 10-membered heterocycloalkyl substituted —C2-10alkenyl, optionally substituted —C2-10 alkynyl, optionally substituted —C1-12 alkoxyl, optionally substituted —C1-12 haloalkyl, optionally substituted C6-10 aryl, optionally substituted C3-7 cycloalkyl, optionally substituted 5- to 10-membered heteroaryl, and optionally substituted 5- to 10-membered heterocycloalkyl.

### Claim 66 (depends on 64)

The transcription modulator molecule of claim 64, wherein Aa is selected from an optionally substituted C6-10 aryl, optionally substituted C3-7 cycloalkyl, optionally substituted 5- to 10 membered heteroaryl, and optionally substituted 5- to 10-membered heterocycloalkyl.

### Claim 67 (depends on 64)

The transcription modulator molecule of claim 64, wherein Aa is an optionally substituted C6-10 aryl.

### Claim 68 (depends on 64)

The transcription modulator molecule of claim 64, wherein the protein binding moiety is a residue of a compound having a structure of Formula (C-3)
wherein:
M1c is CR2b or N; and
each R1b, R2b, R3b, R4b, and R5b are independently selected from the group consisting of H, OH, —NO2, halogen, amine, COOH, COOC1-10alkyl, —NHC(O)—optionally substituted —C1-12 alkyl, —NHC(O)(CH2)1-4NR′R″, —NHC(O)(CH2)0-4 CHR′(NR′R″), —NHC(O)(CH2)0-4 CHR′R″, —NHC(O)(CH2)0-4—C3-7 cycloalkyl, —NHC(O)(CH2)0-4-5- to 10-membered heterocycloalkyl, NHC(O)(CH2)0-4C6-10 aryl, —NHC(O)(CH2)0-4-5- to 10-membered heteroaryl, —(CH2)1-4—C3-7 cycloalkyl, —(CH2)1-4-5- to 10-membered heterocycloalkyl, —(CH2)1-4C6-10 aryl, —(CH2)1-4-5- to 10-membered heteroaryl, optionally substituted —C2-10 alkenyl, optionally substituted —C2-10 alkynyl, optionally substituted —C1-12 alkoxyl, optionally substituted —C1-12 haloalkyl, optionally substituted C6-10 aryl, optionally substituted C3-7cycloalkyl, optionally substituted 5- to 10-membered heteroaryl, and optionally substituted 5- to 10-membered heterocycloalkyl.

### Claim 69 (depends on 68)

The transcription modulator molecule of claim 68, wherein each R1b and R5b are independently hydrogen, halogen, or C1-6alkyl.

### Claim 70 (depends on 68)

The transcription modulator molecule of claim 68, wherein each R2b and R3b are independently H, OH, —NO2, halogen, C1-4 haloalkyl, amine, COOH, COOC1-10alkyl, —NHC(O)—optionally substituted —C1-12 alkyl, —NHC(O)(CH2)1-4NR′R″, —NHC(O)(CH2)0-4 CHR′(NR′R″), —NHC(O)(CH2)0-4 CHR′R″, —NHC(O)(CH2)0-4—C3-7 cycloalkyl, —NHC(O)(CH2)0-4-5- to 10-membered heterocycloalkyl, NHC(O)(CH2)0-4C6-10 aryl, —NHC(O)(CH2)0-4-5- to 10-membered heteroaryl, —(CH2)1-4—C3-7 cycloalkyl, —(CH2)1-4-5- to 10-membered heterocycloalkyl, —(CH2)1-4C6-10 aryl, —(CH—2)1-4-5- to 10-membered heteroaryl, optionally substituted —C2-10 alkenyl, optionally substituted —C2-10 alkynyl, optionally substituted —C1-12 alkoxyl, optionally substituted C6-10 aryl, optionally substituted C3-7 cycloalkyl, optionally substituted 5- to 10-membered heteroaryl, and optionally substituted 5- to 10-membered heterocycloalkyl.

### Claim 71 (depends on 64)

The transcription modulator molecule of claim 64, wherein Aa is a C6-10 aryl substituted with 1-4 substituents, and each substituent is independently selected from halogen, OH, NO2, an optionally substituted —C1-12 alkyl, optionally substituted —C2-10 alkenyl, optionally substituted —C2-10 alkynyl, optionally substituted —C1-12 alkoxyl, optionally substituted —C1-12 haloalkyl, optionally substituted C6-10 aryl, optionally substituted C3-7 cycloalkyl, optionally substituted 5- to 10 membered heteroaryl, and optionally substituted 5- to 10-membered heterocycloalkyl.

### Claim 72 (depends on 64)

The transcription modulator molecule of claim 64, wherein R1a, R3a, and R4a are hydrogen.

### Claim 73 (depends on 64)

The transcription modulator molecule of claim 64, wherein R2a is selected from the group consisting of H, OH, —NO2, halogen, amine, COOH, COOC1-10alkyl, —NHC(O)—optionally substituted —C1-12alkyl, —NHC(O)(CH2)1-4R′R″, —NHC(O)(CH2)0-4 CHR′(NR′R″), —NHC(O)(CH2)0-4 CHR′R″, —NHC(O)(CH2)0-4—C3-7 cycloalkyl, —NHC(O)(CH2)0-4-5- to 10-membered heterocycloalkyl, NHC(O)(CH2)0-4C6-10 aryl, —NHC(O)(CH2)0-4-5- to 10-membered heteroaryl, —((CH2)1-4—C3-7cycloalkyl, —(CH2)1-4-5- to 10-membered heterocycloalkyl, —(CH2)1-4C6-10 aryl, —(CH2)1-4-5- to 10-membered heteroaryl, optionally substituted —C1-12 alkyl, -optionally substituted —C2-10 alkenyl, optionally substituted —C2-10 alkynyl, optionally substituted —C1-12 alkoxyl optionally substituted —C1-12 haloalkyl, optionally substituted C6-10 aryl, optionally substituted C3-7cycloalkyl, optionally substituted 5- to 10-membered heteroaryl, and optionally substituted 5- to 10-membered heterocycloalkyl.

### Claim 74 (depends on 64)

The transcription modulator molecule of claim 64, wherein R2a is an phenyl or pyridinyl optionally substituted with 1-3 substituents, wherein the substituent is independently selected from the group consisting of OH, —NO2, halogen, amine, COOH, COOC1-10alkyl, —NHC(O)—C1-12 alkyl, —NHC(O)(CH2)1-4NR′R″, —NHC(O)(CH2)0-4 CHR′(NR′R″), —NHC(O)(CH2)0-4 CHR′R″, —NHC(O)(CH2)0-4—C3-7 cycloalkyl, —NHC(O)(CH2)0-4-5- to 10-membered heterocycloalkyl, NHC(O)(CH2)0-4C6-10 aryl, —NHC(O)(CH2)0-4-5- to 10-membered heteroaryl, —(CH2)1-4—C3-7 cycloalkyl, —(CH2)1-4-5- to 10-membered heterocycloalkyl, —(CH2)C6-10 aryl, —(CH2)1-4-5- to 10-membered heteroaryl, —C1-12 alkoxyl, C1-12 haloalkyl, C6-10 aryl, C3-7 cycloalkyl, 5- to 10-membered heteroaryl, and 5- to 10-membered heterocycloalkyl.

### Claim 75 (depends on 1)

The transcription modulator of claim 1, wherein the protein binding moiety is a residue of a compound having the structure of
wherein:
R1c is an optionally substituted C6-10 aryl or an optionally substituted 5- to 10-membered heteroaryl,
Xc is —C(O)NH—, —C(O), —S(O2)—, —NH—, or —C1-4alkyl-NH,
n is 0-10,
R2c is —NR3cR4c, optionally substituted C6-10 aryl, optionally substituted C3-7 cycloalkyl, optionally substituted 5- to 10-membered heteroaryl, or optionally substituted 4- to 10-membered heterocycloalkyl; and
each R3c and R4c are independently H or optionally substituted —C1-12 alkyl.

### Claim 76 (depends on 1)

The transcription modulator molecule of claim 1, wherein R2c is —NHC(CH3)3, a 4- to 10-membered heterocycloalkyl substituted with —C1-12 alkyl.

### Claim 77 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62)

The transcription modulator of any one of claims 1-62, wherein the protein binding moiety is a residue of a compound having the structure of Formula (C-5)
wherein:
X2c is a bond, C(O), SO2, or CHR3c;
M2c is CH or N;
R2c is an optionally substituted C6-10 aryl or an optionally substituted 5- to 10-membered heteroaryl,
n is 0-10,
R2c is —NR3cR4c optionally substituted C6-10 aryl, optionally substituted C3-7 cycloalkyl, optionally substituted 5- to 10-membered heteroaryl, or optionally substituted 4- to 10-membered heterocycloalkyl;
each R5c is independently —NR3cR4c, —C(O)R3c, —COOH, —C(O)NHC1-6alkyl an optionally substituted C6-10 aryl, or an optionally substituted 5- to 10-membered heteroaryl;
R6c is —NR3cR4c, —C(O)R3c, an optionally substituted C6-10 aryl, or an optionally substituted 5- to 10-membered heteroaryl, and
each R3c and R4c are independently H, an optionally substituted C6-10 aryl, optionally substituted 4- to 10-membered heterocycloalkyl, or optionally substituted —C1-12 alkyl.

### Claim 78 (depends on 77)

The transcription modulator molecule of claim 77, wherein R2c is a 4- to 10-membered heterocycloalkyl substituted by a 4- to 10-membered heterocycloalkyl.

### Claim 79 (depends on 77)

The transcription modulator molecule of claim 77, wherein R6c is —C(O)R3c—, and R3c is a 4- to 10-membered heterocycloalkyl substituted by a 4- to 10-membered heterocycloalkyl.

### Claim 80 (depends on 77)

The transcription modulator molecule of claim 77, wherein each R5c is independently H, —C(O)R3c, —COOH, —C(O)NHC1-6alkyl, —NH—C6-10 aryl, or optionally substituted C6-10 aryl.

### Claim 81 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62)

The transcription modulator molecule of any one of claims 1-62, wherein the protein binding moiety is a residue of a compound having the structure of Formula (C-6)
Wherein:
X3c is a bond, NH, C1-4 alkylene, or NC1-4 alkyl;
R7c is an optionally substituted C1-6alkyl, an optionally substituted cyclic amine, an optionally substituted aryl, an optionally substituted 5- to 10-membered heteroaryl, optionally substituted 4- to 10-membered heterocycloalkyl,
R8c is H, halogen, or C1-6 alkyl, and
R9c is H, or C1-6 alkyl.

### Claim 82 (depends on 80)

The transcription modulator molecule of claim 80, wherein R7c is an optionally substituted cyclic secondary or tertiary amine.

### Claim 83 (depends on 80)

The transcription modulator molecule of claim 80, wherein R7c is a tetrahydroisoquinoline optionally substituted with C1-4 alkyl.

### Claim 84 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62)

The transcription modulator molecule of any one of claims 1-62, wherein the protein binding moiety is a residue of a compound having the structure of Formula (C-7)
wherein:
A2 is an optionally substituted aryl or heteroaryl,
X2 is (CH2)0-4 or NH, and
B2 is an optionally substituted aryl, heterocyclic, or heteroaryl, linked to an amide group.

### Claim 85 (depends on 84)

The transcription modulator molecule of claim 84, wherein A2 is an aryl substituted with one or more halogen, C1-6alkyl, hydroxyl, C1-6alkoxy, and C1-6haloalkyl.

### Claim 86 (depends on 84)

The transcription modulator molecule of claim 84, wherein X2 is NH.

### Claim 87 (depends on 84)

The transcription modulator molecule of claim 84, wherein B2 is a heterocyclic group.

### Claim 88 (depends on 84)

The transcription modulator molecule of claim 84, wherein B2 is a pyrrolidine.

### Claim 89 (depends on 84)

The transcription modulator molecule of claim 84, wherein B2 is an optionally substituted phenyl.

### Claim 90 (depends on 84)

The transcription modulator molecule of claim 84, wherein B2 is a phenyl optionally substituted with one or more halogen, C1-6 alkyl, hydroxyl, C1-6 alkoxy, and C1-6 haloalkyl.

### Claim 91 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62)

The transcription modulator molecule of any one of claims 1-62, wherein the protein binding moiety is a residue of a compound having the structure of Formula (C-8)
wherein R is OH or OC1-12 alkyl, R1 is H or C1-25 alkyl.

### Claim 92 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62)

The transcription modulator molecule of any one of claims 1-62, wherein the protein binding moiety is a residue of a compound having the structure of Formula (C-9)
wherein R1 is H, OH, —CONH2, —COOH, —NHC(O)—C1-6alkyl, —NHC(O)O—C1-6alkyl, —NHS(O)2—C1-6alkyl, —C1-6alkyl, —C1-6alkoxyl, or —NHC(O)NH—C1-6alkyl,
R2 is H, CN, or CONH2, and
R3 is an optionally substituted C6-10 aryl.

### Claim 93 (depends on 1)

The transcription modulator molecule of claim 1, wherein the protein binding moiety is a residue of a compound having the structure of Formula (C-10)
wherein R1′ is an optionally substituted C6-10 aryl or optionally substituted 5- to 10-membered heteroaryl, and
each R2′ and R3′ are independently H, —C1-4alkyl-C6-10 aryl, —C1-4alkyl-5-to 10-membered heteroaryl, C6-10 aryl, or -5- to 10-membered heteroaryl, or
R2′ and R3′ together with N form an optionally substituted 4-10 membered heterocyclic or heteroaryl group.

### Claim 94 (depends on 62)

The transcription modulator molecule of claim 62, wherein the methylated histone lysine protein is selected from Ankyrin repeats, WD-40 repeat domains, MBT, Tudor, PWWP, chromodomain plant homeodomain (PHD) fingers, and ADD.

### Claim 95 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62)

The transcription modulator molecule of any one of claims 1-62, wherein the second terminus comprises at least one 5-10 membered heteroaryl group having at least two nitrogen atoms.

### Claim 96 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95)

The transcription modulator molecule of any one of claims 1-95, wherein the second terminus comprises a moiety capable of binding to the regulatory protein, and the moiety is from a compound capable of capable of binding to the regulatory protein.

### Claim 97 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62)

The transcription modulator molecule of any one of claims 1-62, wherein the second terminus comprises at least one group selected from an optionally substituted diazine, an optionally substituted diazepine, and an optionally substituted phenyl.

### Claim 98 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97)

The transcription modulator molecule of any one of claims 1-97, wherein the second terminus does not comprises JQ1, iBET762, OTX015, RVX208, or AU1.

### Claim 99 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98)

The transcription modulator molecule of any one of claims 1-98, wherein the second terminus does not comprises JQ1.

### Claim 100 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99)

The transcription modulator molecule of any one of claims 1-99, wherein the second terminus does not comprises a moiety that binds to a bromodomain protein.

### Claim 101 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62)

The transcription modulator molecule of any one of claims 1-62, wherein the second terminus comprises a diazine or diazepine ring wherein the diazine or diazepine ring is fused with a C6-10 aryl or a 5-10 membered heteroaryl ring comprising one or more heteroatom selected from S, N and O.

### Claim 102 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62)

The transcription modulator molecule of any one of claims 1-62, wherein the second terminus comprises an optionally substituted bicyclic or tricyclic structure.

### Claim 103 (depends on 102)

The transcription modulator molecule of claim 102, wherein the optionally substituted bicyclic or tricyclic structure comprises a diazepine ring fused with a thiophene ring.

### Claim 104 (depends on 102)

The transcription modulator molecule of claim 102, wherein the second terminus comprises an optionally substituted bicyclic structure, wherein the bicyclic structure comprises a diazepine ring fused with a thiophene ring.

### Claim 105 (depends on 102)

The transcription modulator molecule of claim 102, wherein the second terminus comprises an optionally substituted tricyclic structure, wherein the tricyclic structure a diazephine ring that is fused with a thiophene and a triazole.

### Claim 106 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62)

The transcription modulator molecule of any one of claims 1-62, wherein the second terminus comprises an optionally substituted diazine ring.

### Claim 107 (depends on 1, 106)

The transcription modulator molecule of any one of claims 1-106, wherein the second terminus does not comprises a structure of formula (C-1) of
Wherein:
each of A1 and B1 is independently an optionally substituted aryl or heteroaryl ring,
X1 is C or N,
R1 is hydrogen, halogen, or an optionally substituted C1-6 alkyl group, and
R2 is an optionally substituted C1-6 alkyl, cycloalkyl, C6-10aryl, or heteroaryl.

### Claim 108 (depends on 107)

The transcription modulator molecule of claim 107, wherein X1 is N.

### Claim 109 (depends on 107)

The transcription modulator molecule of claim 107, wherein A1 is an aryl or heteroaryl substituted with one or more substituents.

### Claim 110 (depends on 107)

The transcription modulator molecule of claim 107, wherein A1 is an aryl or heteroaryl substituted with one or more substituents selected from halogen, C1-6alkyl, hydroxyl, C1-6alkoxy, and C1-6haloalkyl.

### Claim 111 (depends on 107)

The transcription modulator molecule of claim 107, wherein B1 is optionally substituted with one or more substituents selected from halogen, C1-6alkyl, hydroxyl, C1-6alkoxy, and C1-6haloalkyl.

### Claim 112 (depends on 107)

The transcription modulator molecule of claim 107, wherein A1 is an optionally substituted thiophene or phenyl.

### Claim 113 (depends on 107)

The transcription modulator molecule of claim 107, wherein A1 is a thiophene or phenyl, each substituted with one or more substituents selected from halogen, C1-6alkyl, hydroxyl, C1-6alkoxy, and C1-6haloalkyl.

### Claim 114 (depends on 107)

The transcription modulator molecule of claim 107, wherein B1 is an optionally substituted triazole.

### Claim 115 (depends on 107)

The transcription modulator molecule of claim 107, wherein B1 is a triazole substituted with one or more substituents selected from halogen C1-6alkyl, hydroxyl, C1-6alkoxy, and C1-6haloalkyl.

### Claim 116 (depends on 1, 106)

The transcription modulator molecule of any one of claims 1-106, wherein the protein binding moiety is not selected from

### Claim 117 (depends on 1, 106)

The transcription modulator molecule of any one of claims 1-106, wherein the protein binding moiety is not

### Claim 118 (depends on 1, 106)

The transcription modulator molecule of any one of claims 1-106, wherein the protein binding moiety is not Formula (A-4):
wherein:
R1 is a hydrogen or an optionally substituted alkyl, hydroxyalkyl, aminoalkyl, alkoxyalkyl, halogenated alkyl, hydroxyl, alkoxy, or —COOR4;
R4 is a hydrogen, or optionally substituted aryl, aralkyl, cycloalkyl, heteroaryl, heteroaralkyl, heterocycloalkyl, alkyl, alkenyl, alkynyl, or cycloalkylalkyl group optionally interrupted by one or more heteroatoms;
R2 is an optionally substituted aryl, alkyl, cycloalkyl, or aralkyl group; R3 may be a hydrogen, halogen, or optionally substituted alkyl group (e.g., (CH2)x—C(O)N(R20)(R21), (CH2)x—N(R20)—C(O) (R21), or halogenated alkyl group,
x is an integer from 1 to 10, and R20 and R21 may independently be a hydrogen or C1-C6 alkyl group (typically R20 may be a hydrogen and R21 may be a methyl); and
Ring E is an optionally substituted aryl or heteroaryl group.

### Claim 119

A compound as recited in any one of the proceeding claims for use as a medicament.

### Claim 120

A compound as recited in any one of the proceeding claims for use in the manufacture of a medicament for the prevention or treatment of a disease or condition ameliorated by the overexpression of cnbp.

### Claim 121

A compound as recited in any one of the proceeding claims for use in the treatment of DM2.

### Claim 122

A pharmaceutical composition comprising a compound as recited in any one of the proceeding claims together with a pharmaceutically acceptable carrier.

### Claim 123 (depends on 1, 121)

A method of modulation of the expression of cnbp comprising contacting cnbp with a compound as recited in any one of claims 1-121.

### Claim 124 (depends on 1, 121)

A method of treatment of a disease caused by overexpression of cnbp comprising the administration of a therapeutically effective amount of a compound as recited in any one of claims 1-121 to a patient in need thereof.

### Claim 125 (depends on 124)

The method as recited in claim 124 wherein said disease is DM2.

### Claim 126 (depends on 1)

A method of treatment of a disease caused by overexpression of cnbp comprising the administration of:
a. a therapeutically effective amount of a compound as recited in claim 1; and
b. another therapeutic agent.

### Claim 127

A method for achieving an effect in a patient comprising the administration of a therapeutically effective amount of a compound as disclosed herein, or a salt thereof, to a patient, wherein the effect is chosen from muscular disorders and cataracts, and cardiac and respiratory disorders.
